CRISIL Ltd

Stage 2 · Advancing · week 6Setup 4.0 WatchEven -0.8

As of 9 Oct 2026, CRISIL is in Stage 2 — advancing, the uptrend phase, in week 6 (since 27 Aug 2026). It closed at ₹4,424, 11.4% below its 52-week high and above its 200-day average, which is rising. In Financials, 22.0% of stocks are in Stage 2.

CRISIL Limited, an analytical company, provides ratings, research, and risk and policy consulting services in India, Europe, North America, and internationally. More about the company

₹4,423.8
+0.45% today
₹32,351 Cr · Large cap
Market Neutral — FadingFinancials 22.0% in Stage 2-11.7 pts / 20dStock Exchanges & Ratings 42.9%-28.6 pts

Pro read

Pro

Our read

Early entry — still early enough in its move

Setup score

4.0 Watch

Momentum

Steady

Edge

Even -0.8

Setup-score rank among Stage 2 peers: #2 of 3 in Stock Exchanges & Ratings · #31 of 58 in Financials

Is CRISIL early, or has it already run? Pro answers that for every NSE stock, after every close.

₹2,999 · 12 months₹1,999 · 6 months
Loading price chart…
vs 52W High
-11.4%
₹3,705.9 lo₹4,994.4 hi
11.4% below 52W high — pullback range
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 6
1w13w26w
Week 6 — early Stage 2, building
How long this stock has been in Stage 2. The sweet spot is mid-run — enough time to prove the structure holds, not so long it's extended. Very fresh (wk 1–4) often needs more time to confirm.
vs 200 DMA
2.3%
200 DMA: ₹4,322.7 · rising
Long-term trend anchor. When stock and Nifty are both above their 200 DMA, the macro backdrop supports continuation.
Rel Volume
0.35x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↓
MA20 rolling over · -2.9% vs MA50 +3.1%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
1M
-7.0%
3M
+8.0%
6M
+14.8%
YTD
+4.3%
1Y
+0.4%
Sector
Financials
↓ Peaking
Stage 2%
22.0%
20d Δ
-11.7pp
1M return
-4.1%
3M return
-6.7%
Sector Stage-2 % · last 20 days
This stock ranks #37 of 55 Stage 2 stocks in Financials by RS.
Industry
Stock Exchanges & Ratings
↓ Peaking
Stage 2%
42.9%
20d Δ
-28.6pp
1M return
-3.7%
3M return
-1.1%
Industry Stage-2 % · last 20 days
Ranks #2 of 3 Stage 2 stocks in this industry. Top tier.
Stage Cycle Timeline2023-07-14 → 2026-10-09
S2 29w
S2 23w
S4 19w
S4 14w
2023-07-142026-10-09
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 29w → S3 3w → S2 12w → S3 6w → S4 7w → S1 3w → S2 23w → S3 6w → S4 8w → S1 4w → S2 10w → S3 5w → S4 19w → S1 5w → S4 14w → S1 3w → S4 3w → S1 3w → S2 6w current
Total tracked: 168 weeks across 19 stage runs.
Scan Membership
Breakout Watch
Latest: 2026-08-27
4 appearances in last 60 days. First seen: 2024-02-20.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-10-09S2
Wk 6 · Vol 0.35x
2026-10-08S2
Wk 6 · Vol 0.26x
2026-10-07S2
Wk 6 · Vol 0.25x
2026-10-06S2
Wk 6 · Vol 0.20x
2026-10-05S2
Wk 6 · Vol 0.51x
2026-10-01S2
Wk 5 · Vol 0.53x
2026-09-30S2
Wk 5 · Vol 0.59x
2026-09-29S2
Wk 5 · Vol 0.58x
2026-09-28S2
Wk 5 · Vol 2.22x
2026-09-25S2
Wk 5 · Vol 0.58x
2026-09-24S2
Wk 4 · Vol 0.22x
2026-09-23S2
Wk 4 · Vol 0.51x
Sector Peers — Stage 2All →
SMCGLOBAL
wk 10 · 0.0% from hi
9.4
GCSL
wk 15 · 0.0% from hi
8.4
ONELIFECAP
wk 1 · 0.0% from hi
8.2
ARIHANTCAP
wk 4 · -17.9% from hi
7.9
PAISALO
wk 26 · -13.4% from hi
7.5
Moving averages & range
50 DMA
₹4,562.2
200 DMA
₹4,322.7
52W High
₹4,994.4
52W Low
₹3,705.9
5D Low
₹4,404
Resistance levels (recent highs)
20d High
₹4,721.7
60d High
₹4,829.5
120d High
₹4,829.5
250d High
₹4,994.4
Next resistance
+6.7%
to 20d High
Ask the Market AI about CRISILAsk →
P/E (TTM)
34.7
Forward 26.5
Earnings Growth (YoY)
+45.9%
Revenue +30.1%
Dividend Yield
0.90%
P/B 9.6
About this companyFinancials· Stock Exchanges & Ratings

CRISIL Limited, an analytical company, provides ratings, research, and risk and policy consulting services in India, Europe, North America, and internationally. It operates through two segment, Rating Services; and Research, Analytics and Solutions. The company offers credit ratings for corporates, banks, and bank loans; credit analysis services; grading services; and analytical services. It also provides research and risk solutions, industry reports, customized research assignments, subscription to data services, training, and advisory services; and a range of risk management tools, analytics, and solutions for financial institutions, banks, and corporates. The company was formerly known as The Credit Rating Information Services of India Limited and changed its name to CRISIL Limited in December 2003. CRISIL Limited was incorporated in 1987 and is headquartered in Mumbai, India.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-09. Past data patterns are not indicative of future results. This page is a data analytics tool only.